Evidence map›Paper›PMID 40590712›Full record

ArticleAntimicrobial agents and chemotherapy2025

Roya Vahedi-Shahandashti, Eleonora Moroder, Cornelia Lass-Flörl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Observational
  2. Six-month surveillance ofFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Roya Vahedi-ShahandashtiInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-7518-7795
Eleonora MoroderInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Cornelia Lass-FlörlInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-2946-7785

Funding

Austrian Science Fund W1253-B24
6 · The paper itself

Abstract

Antifungal susceptibility testing (AFST) is essential for clinical decisions to effectively select optimal therapy against fungal infections. Reference standard broth microdilution methods provide accurate results; however, they are more challenging and time-consuming compared to conventional susceptibility testing methods such as gradient diffusion strips (Etest). This study assessed the Clinical and Laboratory Standards Institute (CLSI) yeast protocol and Etest for determining the echinocandin susceptibility profile (anidulafungin, caspofungin, micafungin, and rezafungin) in

Indexed as

Antifungal AgentsCandida parapsilosisEchinocandinsAnidulafunginCaspofunginDisk Diffusion Antimicrobial TestsDrug Resistance, FungalFungal ProteinsGlucosyltransferasesHumansLaboratories, ClinicalMicafunginMicrobial Sensitivity TestsAnidulafunginAntifungal AgentsCaspofunginEchinocandinsFungal ProteinsGlucosyltransferasesMicafunginRezafunginanidulafunginCandida parapsilosiscandidiasisechinocandinsechinocandins resistanceEtestfks gene

Identifiers

PMID40590712
PMCPMC12326996

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.